The drug being tested in this study is called alisertib. Alisertib is being tested in adult patients with advanced solid tumors or relapsed refactory lymphoma. The study will look at the effect of the pharmacokinetics (how the drug moves through the body) of alisertib in the presence and absence of itraconazole.